US Pharma MarketingAfter government probe, Sanofi offers to end disparaging claims against CSL flu shot in Europe
Sanofi offers to stop disparaging CSL Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy…
Two weeks after the European Commission launched an investigation into Sanofi, the French drugmaker has offered to stop making negative claims about a rival drugmaker's flu vaccine.
The dispute centered on Sanofi's enhanced flu vaccine ...
Source: Endpoints News